Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis.

Ghadiri M, Rezk A, Li R, Evans A, Giacomini PS, Barnett MH, Antel J, Bar-Or A.

Sci Rep. 2020 Jan 15;10(1):356. doi: 10.1038/s41598-019-57114-2.

2.

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.

Berger T, Brochet B, Brambilla L, Giacomini PS, Montalbán X, Vasco Salgado A, Su R, Bretagne A.

Mult Scler J Exp Transl Clin. 2019 Dec 2;5(4):2055217319887191. doi: 10.1177/2055217319887191. eCollection 2019 Oct-Dec.

3.

Diagnosis and management of secondary-progressive multiple sclerosis: time for change.

Oh J, Alikhani K, Bruno T, Devonshire V, Giacomini PS, Giuliani F, Nakhaipour HR, Schecter R, Larochelle C.

Neurodegener Dis Manag. 2019 Nov 26. doi: 10.2217/nmt-2019-0024. [Epub ahead of print]

4.

Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.

Li R, Rezk A, Ghadiri M, Luessi F, Zipp F, Li H, Giacomini PS, Antel J, Bar-Or A.

J Immunol. 2019 Apr 1;202(7):2172. doi: 10.4049/jimmunol.1900114. Epub 2019 Feb 15. No abstract available.

PMID:
30770414
5.

Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing.

Freedman MS, Selchen D, Prat A, Giacomini PS.

Can J Neurol Sci. 2018 Sep;45(5):489-503. doi: 10.1017/cjn.2018.17. Epub 2018 Jun 12. Review.

PMID:
29893652
6.

Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.

Oh J, Gagné-Brosseau MS, Guenette M, Larochelle C, Lemieux F, Menon S, Morrow SA, Poliquin-Lasnier L, Roy-Hewitson C, Rush C, Trudelle AM, Giacomini PS.

Can J Neurol Sci. 2018 May;45(3):304-312. doi: 10.1017/cjn.2018.7.

PMID:
29756588
7.

Rebound disease in multiple sclerosis.

Giacomini PS.

Mult Scler. 2018 Jul;24(8):1137-1138. doi: 10.1177/1352458518772913. Epub 2018 Apr 30. No abstract available.

PMID:
29708464
8.

Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod.

Ghadiri M, Fitz-Gerald L, Rezk A, Li R, Nyirenda M, Haegert D, Giacomini PS, Bar-Or A, Antel J.

Mult Scler. 2017 Aug;23(9):1225-1232. doi: 10.1177/1352458517713147.

PMID:
28749311
9.

Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis.

Ghadiri M, Rezk A, Li R, Evans A, Luessi F, Zipp F, Giacomini PS, Antel J, Bar-Or A.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 23;4(3):e340. doi: 10.1212/NXI.0000000000000340. eCollection 2017 May.

10.

Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.

Li R, Rezk A, Ghadiri M, Luessi F, Zipp F, Li H, Giacomini PS, Antel J, Bar-Or A.

J Immunol. 2017 Jan 15;198(2):691-698. doi: 10.4049/jimmunol.1601649. Epub 2016 Dec 14. Erratum in: J Immunol. 2019 Apr 1;202(7):2172.

11.

Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.

Michell-Robinson MA, Moore CS, Healy LM, Osso LA, Zorko N, Grouza V, Touil H, Poliquin-Lasnier L, Trudelle AM, Giacomini PS, Bar-Or A, Antel JP.

Ann Clin Transl Neurol. 2015 Dec 2;3(1):27-41. doi: 10.1002/acn3.270. eCollection 2016 Jan.

12.

Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.

Duquette P, Giacomini PS, Bhan V, Hohol M, Schecter R.

Can J Neurol Sci. 2016 Jan;43(1):33-43. doi: 10.1017/cjn.2015.302. Epub 2015 Nov 27. Review.

PMID:
26611431
13.

Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.

Leppert IR, Narayanan S, Araújo D, Giacomini PS, Lapierre Y, Arnold DL, Pike GB.

J Neurol. 2014 Apr;261(4):809-16. doi: 10.1007/s00415-014-7284-0. Epub 2014 Feb 26.

PMID:
24570281
14.

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.

Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis–Associated PML–IRIS (MIMSAPI) Group.

N Engl J Med. 2014 Jan 30;370(5):486-8. doi: 10.1056/NEJMc1304828. No abstract available.

15.

Laquinimod in multiple sclerosis.

Giacomini PS, Bar-Or A.

Clin Immunol. 2012 Jan;142(1):38-43. doi: 10.1016/j.clim.2011.02.021. Epub 2011 Mar 4. Review.

PMID:
21450529
16.

Reproducibility of quantitative magnetization-transfer imaging parameters from repeated measurements.

Levesque IR, Sled JG, Narayanan S, Giacomini PS, Ribeiro LT, Arnold DL, Pike GB.

Magn Reson Med. 2010 Aug;64(2):391-400. doi: 10.1002/mrm.22350.

17.

Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis.

Derakhshan M, Caramanos Z, Giacomini PS, Narayanan S, Maranzano J, Francis SJ, Arnold DL, Collins DL.

Neuroimage. 2010 Oct 1;52(4):1261-7. doi: 10.1016/j.neuroimage.2010.05.029. Epub 2010 May 17.

PMID:
20483380
18.

Quantitative magnetization transfer and myelin water imaging of the evolution of acute multiple sclerosis lesions.

Levesque IR, Giacomini PS, Narayanan S, Ribeiro LT, Sled JG, Arnold DL, Pike GB.

Magn Reson Med. 2010 Mar;63(3):633-40. doi: 10.1002/mrm.22244.

19.

Antigen-specific therapies in multiple sclerosis.

Giacomini PS, Bar-Or A.

Expert Opin Emerg Drugs. 2009 Sep;14(3):551-60. doi: 10.1517/14728210903203790. Review.

PMID:
19708820
20.

Emerging multiple sclerosis disease-modifying therapies.

Giacomini PS, Darlington PJ, Bar-Or A.

Curr Opin Neurol. 2009 Jun;22(3):226-32. Review.

PMID:
19434781
21.

Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.

Giacomini PS, Levesque IR, Ribeiro L, Narayanan S, Francis SJ, Pike GB, Arnold DL.

Arch Neurol. 2009 Mar;66(3):375-81. doi: 10.1001/archneurol.2008.578.

PMID:
19273757
22.

Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?

Giacomini PS, Arnold DL, Bar-Or A, Antel JP.

Arch Neurol. 2009 Jan;66(1):19-20. doi: 10.1001/archneurol.2008.529. No abstract available.

PMID:
19139295
23.

Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis.

Giacomini PS, Arnold DL.

Curr Opin Neurol. 2008 Jun;21(3):272-7. doi: 10.1097/WCO.0b013e328300525b. Review.

PMID:
18451709
24.

Fabry's disease presenting as stroke in a young female.

Giacomini PS, Shannon PT, Clarke JT, Jaigobin C.

Can J Neurol Sci. 2004 Feb;31(1):112-4.

PMID:
15038481
25.

Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.

Becher B, Giacomini PS, Pelletier D, McCrea E, Prat A, Antel JP.

Ann Neurol. 1999 Feb;45(2):247-50.

PMID:
9989628
26.

Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12.

Becher B, Blain M, Giacomini PS, Antel JP.

J Immunol. 1999 Jan 15;162(2):684-8.

Supplemental Content

Loading ...
Support Center